Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erdosteine for long-term therapy of COPD
2008-008192-34Phase 3Completed
- Sponsor
- Edmond Pharma
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Erdosteine with Placebo (2 arms). Primary endpoint: Number of acute exacerbations of COPD. Started Jun 2009; status: completed.
02
Drugs
erdosteine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-008192-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008192-34.